Two Cases of Immune Checkpoint Inhibitor- Induced Myocarditis With Complete Atrioventricular Block

被引:5
作者
Kondo, Hisaya [1 ]
Kirigaya, Jin [2 ]
Matsuzawa, Yasushi [1 ]
Hibi, Kiyoshi [1 ]
机构
[1] Yokohama City Univ, Cardiol, Med Ctr, Yokohama, Japan
[2] Yokohama City Univ, Emergency & Crit Care, Med Ctr, Yokohama, Japan
关键词
myocarditis; immune-related adverse event; complete atrioventricular block; cardio-oncology; case report;
D O I
10.7759/cureus.36446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune checkpoint inhibitor-induced myocarditis (ICIM) has been reported to be complicated by a complete atrioventricular block. Even though steroids are used in the treatment thereof, there is no standard protocol for their use. We report two cases of ICIM with a complete atrioventricular block with different outcomes. In the first case, the complete atrioventricular block did not recover. In contrast, in the second case, the complete atrioventricular block did recover. We discuss the different courses and outcomes of the two cases in relation to steroid use.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis
    Tanabe, Junya
    Watanabe, Nobuhide
    Endo, Akihiro
    Nagami, Taichi
    Inagaki, Satoshi
    Tanabe, Kazuaki
    INTERNAL MEDICINE, 2021, 60 (04) : 569 - 573
  • [22] Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis
    Nishikawa, Tatsuya
    Kunimasa, Kei
    Ohta-Ogo, Keiko
    Ikeda, Yoshihiko
    Yasui, Taku
    Shioyama, Wataru
    Oka, Toru
    Honma, Keiichiro
    Hatakeyama, Kinta
    Kumagai, Toru
    Fujita, Masashi
    INTERNAL MEDICINE, 2022, 61 (14) : 2161 - 2165
  • [23] Biomarkers for Immune Checkpoint Inhibitor-Induced Myocarditis Caution Needed
    Jaffe, Allan S.
    JACC: CARDIOONCOLOGY, 2022, 4 (05): : 701 - 703
  • [24] Immune checkpoint inhibitor-related myocarditis
    Tajiri, Kazuko
    Aonuma, Kazutaka
    Sekine, Ikuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (01) : 7 - 12
  • [25] Insight of immune checkpoint inhibitor related myocarditis
    Pi, Jin-kui
    Chen, Xiao-ting
    Zhang, Yan-jing
    Chen, Xue-mei
    Wang, Yin-chan
    Xu, Jia-yi
    Zhou, Jin-han
    Yu, Shuai-shuai
    Wu, Si-si
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [26] Management of Immune Checkpoint Inhibitor Mediated Myocarditis
    Mudra, Sarah
    Culver, Austin
    Kumar, Ashwin
    Yesilyaprak, Abdullah
    Agrawal, Ankit
    Dey, Amit K.
    Rizk, Alexander
    Li, Jason
    Johnson, Adam
    McGowan, Kevin
    Majid, Muhammad
    Njus, Meredith
    Lawrence, Luke
    Klein, Allan L.
    CIRCULATION, 2023, 148
  • [27] Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
    Wang, Dong
    Bauersachs, Johann
    Berliner, Dominik
    BIOLOGY-BASEL, 2023, 12 (03):
  • [28] Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases
    Pathak, Ranjan
    Katel, Anjan
    Massarelli, Erminia
    Villaflor, Victoria M.
    Sun, Virginia
    Salgia, Ravi
    ONCOLOGIST, 2021, 26 (12) : 1052 - 1061
  • [29] Immune checkpoint inhibitor-induced myocarditis in lung cancer patients: a case report of sintilimab-induced myocarditis and a review of the literature
    Bi, Huanhuan
    Ren, Dunqiang
    Wang, Qiang
    Ding, Xiaoqian
    Wang, Hongmei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 793 - 802
  • [30] Complete Atrioventricular Block in COVID-19-Related Myocarditis: A Case Report
    Amir, Muzakkir
    IRANIAN HEART JOURNAL, 2023, 24 (02): : 108 - 113